Technical analysis of Grifols, S.A. (GRFS): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Grifols, S.A., a company founded in 1940 and headquartered in Barcelona, Spain, specializes in the development, manufacture, and distribution of therapeutic products, with a primary focus on those derived from human plasma. Its operations are organized into several divisions.
Price Performance
| 1 month | +10.81% |
| 3 months | +0.37% |
| Year-to-date | -13.37% |
| 1 year | -13.55% |
| 3 years | -13.00% |
| 5 years | -37.35% |
| 10 years | -44.52% |
52-Week Range
| 52-week High | $9.90 |
| 52-week Low | $6.96 |
| Avg Volume (90d) | 620K |
Technical Indicators
| SMA 50 | $7.59 |
| SMA 200 | $8.00 |
| Beta | 1.21 |
| 30-day Volatility (annualised) | 26.5% |
| Price vs SMA 50 | +6.7% |
| Price vs SMA 200 | +1.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $9.35 | |
| 2026-01 | $9.25 | -1.1% |
| 2026-02 | $9.10 | -1.6% |
| 2026-03 | $8.02 | -11.9% |
| 2026-04 | $8.24 | +2.7% |
| 2026-05 | $7.85 | -4.7% |
| 2026-06 | $7.08 | -9.8% |
| 2026-07 | $7.87 | +11.2% |
| 2026-08 | $7.72 | -1.9% |
| 2026-09 | $7.31 | -5.3% |
| 2026-10 | $8.10 | +10.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-02 | $0.32 | $2.21B |
| 2026-07-28 | $0.27 | $2.17B |
| 2026-05-07 | $0.16 | $2.03B |
| 2026-02-26 | $0.29 | $2.34B |
| 2025-11-04 | $0.24 | $2.15B |
| 2025-07-29 | $0.23 | $2.20B |
| 2025-05-12 | $0.15 | $1.96B |
Price
| Price | $8.10 (closing price, October 30, 2026) |
| Market Cap | $6.9B |
| Exchange | NASDAQ |
| Country | ES |
Valuation Ratios
| P/E Ratio | 16.38 |
| Price / Book | 1.35 |
| Dividend Yield | 0.75% |
Financial Health
| Debt / Equity | 1.54 |
| Current Ratio | 2.37 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 1.02 |